Colgate-Palmolive (NYSE:CL) Reaches New 1-Year Low - Time to Sell?

Key Points

• Colgate-Palmolive's stock has hit a new 1-year low at **$82.29**, down from a previous close of **$84.28**, indicating a significant drop in market value.
• Several analysts have issued price target changes, with Citigroup lowering its target from **$108 to $105**, while Wells Fargo cut theirs from **$88 to $83**, and the average target price now sits at **$98** with a "Moderate Buy" rating.
• Colgate-Palmolive recently declared a quarterly dividend of **$0.52** per share, reflecting a **2.5% yield**, and an estimated annual payout ratio of **58.43%**.

Colgate-Palmolive Company (NYSE:CL - Get Free Report)'s share price hit a new 52-week low on Wednesday . The company traded as low as $82.29 and last traded at $82.49, with a volume of 991638 shares traded. The stock had previously closed at $84.28.

Analyst Ratings Changes

A number of research firms have commented on CL. Citigroup cut their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a report on Monday, August 4th. Wells Fargo & Company reduced their target price on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research report on Monday, August 4th. Morgan Stanley decreased their price objective on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Finally, Barclays lifted their price target on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of "Moderate Buy" and an average target price of $98.00.

Colgate-Palmolive Stock Down 1.0%

The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The firm has a market cap of $67.45 billion, a P/E ratio of 23.41, a P/E/G ratio of 4.38 and a beta of 0.35. The firm's fifty day moving average is $86.45 and its 200 day moving average is $89.69.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. The company had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company's quarterly revenue was up 1.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.91 EPS. As a group, equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a dividend of $0.52 per share. The ex-dividend date was Friday, July 18th. This represents a $2.08 annualized dividend and a yield of 2.5%. Colgate-Palmolive's dividend payout ratio is currently 58.43%.

Institutional Trading of Colgate-Palmolive

Institutional investors and hedge funds have recently made changes to their positions in the business. Westend Capital Management LLC grew its stake in shares of Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after acquiring an additional 140 shares during the last quarter. Westside Investment Management Inc. raised its position in Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company's stock valued at $26,000 after purchasing an additional 130 shares in the last quarter. Cornerstone Planning Group LLC grew its stake in Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock worth $28,000 after buying an additional 287 shares during the last quarter. Saudi Central Bank acquired a new position in Colgate-Palmolive during the 1st quarter worth approximately $29,000. Finally, Vermillion & White Wealth Management Group LLC boosted its position in Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company's stock worth $30,000 after purchasing an additional 155 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.